Search

Your search keyword '"Kazdova, L."' showing total 138 results

Search Constraints

Start Over You searched for: Author "Kazdova, L." Remove constraint Author: "Kazdova, L."
138 results on '"Kazdova, L."'

Search Results

101. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

102. The impact of phosphodiesterase-5 inhibition or angiotensin-converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload.

103. Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats.

104. The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach.

105. Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome.

106. Fenofibrate Decreases Hepatic P-Glycoprotein in a Rat Model of Hereditary Hypertriglyceridemia.

107. The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.

108. The Effect of Meal Frequency on the Fatty Acid Composition of Serum Phospholipids in Patients with Type 2 Diabetes.

109. Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: improvement of lipid metabolism.

111. Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation.

112. Conjugated linoleic acid reduces visceral and ectopic lipid accumulation and insulin resistance in chronic severe hypertriacylglycerolemia.

113. Carnitine supplementation alleviates lipid metabolism derangements and protects against oxidative stress in non-obese hereditary hypertriglyceridemic rats.

115. Differential acute postprandial effects of processed meat and isocaloric vegan meals on the gastrointestinal hormone response in subjects suffering from type 2 diabetes and healthy controls: a randomized crossover study.

116. Postprandial oxidative stress and gastrointestinal hormones: is there a link?

117. Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: a randomised crossover study.

118. Autophagy inhibition in early but not in later stages prevents 3T3-L1 differentiation: Effect on mitochondrial remodeling.

119. Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages.

120. Epinephrine-dependent control of glucose metabolism in white adipose tissue: the role of α- and β-adrenergic signalling.

121. The increased activity of liver lysosomal lipase in nonalcoholic Fatty liver disease contributes to the development of hepatic insulin resistance.

122. The opposite effects of high-sucrose and high-fat diet on Fatty Acid oxidation and very low density lipoprotein secretion in rat model of metabolic syndrome.

123. Comparison of gene expression of epicardial and visceral adipocytes with regard to the differentiation stage.

124. Role of FAT/CD36 in novel PKC isoform activation in heart of spontaneously hypertensive rats.

125. Metabolic characterization of volume overload heart failure due to aorto-caval fistula in rats.

126. Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats.

127. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.

128. Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension.

129. Identification of mutated Srebf1 as a QTL influencing risk for hepatic steatosis in the spontaneously hypertensive rat.

130. Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains.

131. Genetic relationship between placental and fetal weights and markers of the metabolic syndrome in rat recombinant inbred strains.

132. Dynamic genetic architecture of metabolic syndrome attributes in the rat.

133. Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.

134. Captopril enhanced insulin-stimulated glycogen synthesis in skeletal muscle but not fatty acid synthesis in adipose tissue of hereditary hypertriglyceridemic rats.

135. Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain.

136. Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone.

137. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats.

138. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension.

Catalog

Books, media, physical & digital resources